Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardial Infarction | 8 | 2022 | 915 | 1.960 |
Why?
|
| Vietnam | 15 | 2024 | 175 | 1.040 |
Why?
|
| Hospitalization | 6 | 2018 | 1368 | 0.950 |
Why?
|
| Hypertension | 6 | 2023 | 593 | 0.880 |
Why?
|
| Patients | 2 | 2021 | 113 | 0.790 |
Why?
|
| Clinical Laboratory Services | 1 | 2021 | 5 | 0.700 |
Why?
|
| Medical Laboratory Personnel | 1 | 2021 | 10 | 0.700 |
Why?
|
| Hospital Mortality | 5 | 2022 | 870 | 0.700 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2022 | 96 | 0.660 |
Why?
|
| Shock, Cardiogenic | 2 | 2022 | 104 | 0.660 |
Why?
|
| Patient Education as Topic | 3 | 2023 | 478 | 0.610 |
Why?
|
| Water Pollutants, Chemical | 1 | 2019 | 43 | 0.570 |
Why?
|
| Chitosan | 1 | 2019 | 86 | 0.560 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 460 | 0.560 |
Why?
|
| Sample Size | 1 | 2017 | 66 | 0.530 |
Why?
|
| Hospital Administration | 2 | 2014 | 43 | 0.520 |
Why?
|
| Life Style | 1 | 2018 | 317 | 0.500 |
Why?
|
| Aged | 20 | 2024 | 14648 | 0.500 |
Why?
|
| Forecasting | 1 | 2017 | 233 | 0.490 |
Why?
|
| Sex Factors | 4 | 2014 | 979 | 0.480 |
Why?
|
| Healthcare Disparities | 2 | 2010 | 374 | 0.470 |
Why?
|
| Health Behavior | 1 | 2018 | 474 | 0.460 |
Why?
|
| Cardiovascular Diseases | 3 | 2020 | 848 | 0.440 |
Why?
|
| Patient Selection | 1 | 2017 | 487 | 0.440 |
Why?
|
| Developing Countries | 4 | 2023 | 94 | 0.420 |
Why?
|
| Male | 26 | 2024 | 30294 | 0.410 |
Why?
|
| Age Factors | 4 | 2018 | 1569 | 0.390 |
Why?
|
| Female | 27 | 2024 | 33350 | 0.390 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2019 | 771 | 0.390 |
Why?
|
| Sex Characteristics | 1 | 2014 | 202 | 0.380 |
Why?
|
| Acute Coronary Syndrome | 2 | 2018 | 253 | 0.380 |
Why?
|
| Aedes | 4 | 2016 | 12 | 0.370 |
Why?
|
| Risk Assessment | 2 | 2017 | 2046 | 0.370 |
Why?
|
| Humans | 40 | 2024 | 64238 | 0.370 |
Why?
|
| Dengue | 4 | 2016 | 96 | 0.360 |
Why?
|
| Dengue Virus | 3 | 2015 | 99 | 0.320 |
Why?
|
| Myocardial Revascularization | 1 | 2010 | 76 | 0.320 |
Why?
|
| Outpatients | 2 | 2022 | 140 | 0.310 |
Why?
|
| Nurses | 2 | 2021 | 109 | 0.310 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 104 | 0.300 |
Why?
|
| Noncommunicable Diseases | 2 | 2019 | 18 | 0.300 |
Why?
|
| Middle Aged | 14 | 2022 | 17898 | 0.300 |
Why?
|
| Patient Satisfaction | 3 | 2021 | 438 | 0.300 |
Why?
|
| Transportation of Patients | 1 | 2009 | 50 | 0.290 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 5520 | 0.280 |
Why?
|
| Heart Block | 1 | 2008 | 22 | 0.280 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 462 | 0.280 |
Why?
|
| Inpatients | 1 | 2010 | 303 | 0.270 |
Why?
|
| Prognosis | 4 | 2018 | 1769 | 0.250 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 2478 | 0.230 |
Why?
|
| Incidence | 5 | 2018 | 1383 | 0.230 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2009 | 489 | 0.220 |
Why?
|
| Adult | 15 | 2023 | 17116 | 0.220 |
Why?
|
| Pharmacists | 3 | 2020 | 129 | 0.210 |
Why?
|
| Risk Factors | 6 | 2018 | 5339 | 0.190 |
Why?
|
| Adenoma | 1 | 2023 | 67 | 0.190 |
Why?
|
| Esophagitis | 1 | 2022 | 9 | 0.190 |
Why?
|
| Peptic Ulcer | 1 | 2022 | 19 | 0.190 |
Why?
|
| Coronary Artery Bypass | 2 | 2018 | 297 | 0.190 |
Why?
|
| Pain Measurement | 2 | 2021 | 348 | 0.190 |
Why?
|
| Propofol | 1 | 2022 | 23 | 0.180 |
Why?
|
| Gastroesophageal Reflux | 1 | 2022 | 89 | 0.180 |
Why?
|
| Ketamine | 1 | 2022 | 38 | 0.180 |
Why?
|
| Public Health | 2 | 2021 | 186 | 0.170 |
Why?
|
| Mobile Applications | 1 | 2023 | 140 | 0.170 |
Why?
|
| Treatment Outcome | 5 | 2018 | 5691 | 0.170 |
Why?
|
| Drug Hypersensitivity | 1 | 2021 | 28 | 0.170 |
Why?
|
| Blood Culture | 1 | 2020 | 10 | 0.170 |
Why?
|
| Time Factors | 4 | 2018 | 3724 | 0.160 |
Why?
|
| Dementia | 1 | 2024 | 263 | 0.160 |
Why?
|
| Frailty | 1 | 2022 | 125 | 0.160 |
Why?
|
| Pharmacy Technicians | 1 | 2019 | 3 | 0.150 |
Why?
|
| Surveys and Questionnaires | 4 | 2021 | 2737 | 0.150 |
Why?
|
| Bacteremia | 1 | 2020 | 94 | 0.150 |
Why?
|
| Videotape Recording | 1 | 2019 | 46 | 0.150 |
Why?
|
| Computers, Handheld | 1 | 2019 | 38 | 0.150 |
Why?
|
| Atrial Fibrillation | 2 | 2018 | 854 | 0.150 |
Why?
|
| Perception | 1 | 2020 | 178 | 0.150 |
Why?
|
| Hospitals | 1 | 2022 | 390 | 0.150 |
Why?
|
| Infection Control | 1 | 2020 | 105 | 0.150 |
Why?
|
| Charcoal | 1 | 2019 | 6 | 0.150 |
Why?
|
| Magnetic Phenomena | 1 | 2019 | 7 | 0.150 |
Why?
|
| Stakeholder Participation | 1 | 2019 | 27 | 0.150 |
Why?
|
| Pandemics | 2 | 2023 | 676 | 0.150 |
Why?
|
| Pharmaceutical Services | 1 | 2019 | 33 | 0.150 |
Why?
|
| Coffee | 1 | 2019 | 18 | 0.150 |
Why?
|
| Massachusetts | 3 | 2017 | 2094 | 0.150 |
Why?
|
| Ions | 1 | 2019 | 57 | 0.150 |
Why?
|
| Tea | 1 | 2019 | 32 | 0.150 |
Why?
|
| Patient Compliance | 1 | 2021 | 362 | 0.150 |
Why?
|
| Adsorption | 1 | 2019 | 86 | 0.150 |
Why?
|
| Prospective Studies | 4 | 2023 | 3315 | 0.140 |
Why?
|
| Prevalence | 3 | 2022 | 1407 | 0.140 |
Why?
|
| Warfarin | 1 | 2019 | 122 | 0.140 |
Why?
|
| Insect Vectors | 2 | 2015 | 15 | 0.140 |
Why?
|
| Short Bowel Syndrome | 1 | 2018 | 5 | 0.140 |
Why?
|
| Growth | 1 | 2018 | 22 | 0.140 |
Why?
|
| Talaromyces | 1 | 2017 | 1 | 0.140 |
Why?
|
| Itraconazole | 1 | 2017 | 13 | 0.140 |
Why?
|
| Growth Disorders | 1 | 2018 | 29 | 0.140 |
Why?
|
| Dermatomycoses | 1 | 2017 | 13 | 0.140 |
Why?
|
| Minority Groups | 1 | 2019 | 141 | 0.140 |
Why?
|
| Multiple Chronic Conditions | 1 | 2018 | 39 | 0.140 |
Why?
|
| Medication Adherence | 1 | 2019 | 205 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 462 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 788 | 0.130 |
Why?
|
| Plant Extracts | 1 | 2019 | 174 | 0.130 |
Why?
|
| Rural Population | 1 | 2019 | 212 | 0.130 |
Why?
|
| Poverty | 1 | 2019 | 299 | 0.130 |
Why?
|
| Kinetics | 1 | 2019 | 766 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 210 | 0.130 |
Why?
|
| Single-Blind Method | 1 | 2017 | 144 | 0.130 |
Why?
|
| Antifungal Agents | 1 | 2017 | 128 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 223 | 0.130 |
Why?
|
| Child Development | 1 | 2018 | 85 | 0.130 |
Why?
|
| Mosquito Control | 1 | 2016 | 8 | 0.120 |
Why?
|
| Quality of Life | 1 | 2024 | 1257 | 0.120 |
Why?
|
| Insect Repellents | 1 | 2016 | 3 | 0.120 |
Why?
|
| Cause of Death | 1 | 2017 | 222 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2019 | 270 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 437 | 0.120 |
Why?
|
| Culture | 2 | 2016 | 80 | 0.120 |
Why?
|
| Wolbachia | 1 | 2015 | 3 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2019 | 1019 | 0.110 |
Why?
|
| Clinical Protocols | 1 | 2016 | 135 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 513 | 0.110 |
Why?
|
| Income | 3 | 2021 | 172 | 0.110 |
Why?
|
| Health Education | 1 | 2016 | 190 | 0.110 |
Why?
|
| Pain | 3 | 2022 | 407 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2015 | 90 | 0.110 |
Why?
|
| Viruses | 1 | 2015 | 81 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2015 | 123 | 0.100 |
Why?
|
| Caregivers | 1 | 2016 | 283 | 0.100 |
Why?
|
| Odds Ratio | 2 | 2012 | 759 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2022 | 6726 | 0.090 |
Why?
|
| Comorbidity | 1 | 2014 | 1118 | 0.090 |
Why?
|
| Smoking Prevention | 1 | 2012 | 162 | 0.080 |
Why?
|
| South America | 1 | 2010 | 26 | 0.080 |
Why?
|
| New Zealand | 1 | 2010 | 43 | 0.080 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2010 | 24 | 0.080 |
Why?
|
| North America | 1 | 2010 | 112 | 0.080 |
Why?
|
| Physicians | 1 | 2016 | 483 | 0.080 |
Why?
|
| Australia | 1 | 2010 | 126 | 0.080 |
Why?
|
| Europe | 1 | 2010 | 197 | 0.080 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 143 | 0.080 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2010 | 167 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2010 | 153 | 0.080 |
Why?
|
| Aspirin | 1 | 2010 | 172 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 467 | 0.070 |
Why?
|
| Ambulatory Care Facilities | 2 | 2019 | 106 | 0.070 |
Why?
|
| Acute Disease | 1 | 2010 | 672 | 0.070 |
Why?
|
| Logistic Models | 2 | 2012 | 1270 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 215 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2010 | 233 | 0.070 |
Why?
|
| Young Adult | 5 | 2019 | 4776 | 0.070 |
Why?
|
| Adaptation, Psychological | 1 | 2009 | 270 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 318 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2012 | 551 | 0.060 |
Why?
|
| Registries | 1 | 2010 | 885 | 0.060 |
Why?
|
| Quality of Health Care | 1 | 2010 | 526 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 2616 | 0.060 |
Why?
|
| Adolescent | 4 | 2020 | 6304 | 0.060 |
Why?
|
| Data Collection | 2 | 2019 | 384 | 0.060 |
Why?
|
| Quarantine | 1 | 2023 | 11 | 0.050 |
Why?
|
| Ghana | 1 | 2023 | 14 | 0.050 |
Why?
|
| Cathartics | 1 | 2023 | 9 | 0.050 |
Why?
|
| Kenya | 1 | 2023 | 93 | 0.050 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2022 | 22 | 0.050 |
Why?
|
| Manometry | 1 | 2022 | 25 | 0.050 |
Why?
|
| Colonoscopy | 1 | 2023 | 95 | 0.050 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2022 | 74 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2018 | 1375 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2024 | 293 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2022 | 176 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2022 | 76 | 0.040 |
Why?
|
| Infant | 2 | 2018 | 1664 | 0.040 |
Why?
|
| Fentanyl | 1 | 2022 | 75 | 0.040 |
Why?
|
| Analgesics | 1 | 2022 | 102 | 0.040 |
Why?
|
| Developed Countries | 1 | 2021 | 16 | 0.040 |
Why?
|
| Penicillins | 1 | 2021 | 30 | 0.040 |
Why?
|
| Frail Elderly | 1 | 2022 | 107 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2021 | 84 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2022 | 160 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2020 | 11 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 2020 | 106 | 0.040 |
Why?
|
| Community Health Workers | 1 | 2020 | 41 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 296 | 0.040 |
Why?
|
| United States | 3 | 2018 | 7923 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2022 | 414 | 0.040 |
Why?
|
| Telephone | 1 | 2019 | 122 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2018 | 99 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 183 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 2018 | 21 | 0.030 |
Why?
|
| Nursing Homes | 1 | 2024 | 672 | 0.030 |
Why?
|
| Enteral Nutrition | 1 | 2018 | 55 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2018 | 99 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 490 | 0.030 |
Why?
|
| Animals | 4 | 2016 | 20961 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 531 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1681 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2017 | 374 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2016 | 44 | 0.030 |
Why?
|
| Exercise | 1 | 2023 | 954 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 859 | 0.030 |
Why?
|
| Disease Vectors | 1 | 2015 | 7 | 0.030 |
Why?
|
| Nasopharynx | 1 | 2015 | 22 | 0.030 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2015 | 16 | 0.030 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2015 | 18 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2018 | 368 | 0.030 |
Why?
|
| Viremia | 1 | 2015 | 44 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2019 | 511 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2016 | 194 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2019 | 455 | 0.030 |
Why?
|
| Saliva | 1 | 2015 | 100 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2015 | 58 | 0.030 |
Why?
|
| Skin | 1 | 2017 | 385 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 165 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 800 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 818 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2018 | 507 | 0.030 |
Why?
|
| Longevity | 1 | 2015 | 116 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 544 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2015 | 272 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 424 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2018 | 2018 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2012 | 95 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 239 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2012 | 147 | 0.020 |
Why?
|
| Psychometrics | 1 | 2012 | 385 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 2604 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2370 | 0.020 |
Why?
|
| Smoking | 1 | 2012 | 861 | 0.020 |
Why?
|